Cara Therapeutic Shares Outstanding vs. Price To Earning
| CARA Stock | USD 5.12 0.08 1.59% |
For Cara Therapeutic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cara Therapeutic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cara Therapeutic utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cara Therapeutic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cara Therapeutic over time as well as its relative position and ranking within its peers.
Cara |
Cara Therapeutic's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.00) | Revenue Per Share | Quarterly Revenue Growth (0.86) | Return On Assets | Return On Equity |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cara Therapeutic Price To Earning vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cara Therapeutic's current stock value. Our valuation model uses many indicators to compare Cara Therapeutic value to that of its competitors to determine the firm's financial worth. Cara Therapeutic is number one stock in shares outstanding category among its peers. It also is number one stock in price to earning category among its peers . The ratio of Shares Outstanding to Price To Earning for Cara Therapeutic is about 73,093 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cara Therapeutic's earnings, one of the primary drivers of an investment's value.Cara Price To Earning vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Cara Therapeutic |
| = | 4.57 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Cara Therapeutic |
| = | 62.54 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Cara Price To Earning Comparison
Cara Therapeutic is currently under evaluation in price to earning category among its peers.
Cara Therapeutic Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cara Therapeutic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cara Therapeutic will eventually generate negative long term returns. The profitability progress is the general direction of Cara Therapeutic's change in net profit over the period of time. It can combine multiple indicators of Cara Therapeutic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -299 K | -313.9 K | |
| Operating Income | -109.3 M | -103.9 M | |
| Income Before Tax | -106.7 M | -101.3 M | |
| Total Other Income Expense Net | 3.4 M | 3.6 M | |
| Net Loss | -106.7 M | -101.3 M | |
| Income Tax Expense | 82 K | 86.1 K | |
| Net Loss | -104.9 M | -99.6 M | |
| Net Loss | -76.9 M | -80.8 M | |
| Interest Income | 5.2 M | 5.4 M | |
| Non Operating Income Net Other | 2.4 M | 2 M | |
| Net Interest Income | -543.6 K | -516.4 K | |
| Change To Netincome | 20.4 M | 10.7 M | |
| Net Loss | (2.52) | (2.64) | |
| Income Quality | 0.70 | 0.47 | |
| Net Income Per E B T | 0.88 | 0.80 |
Cara Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cara Therapeutic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cara Therapeutic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cara Therapeutic's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Cara Therapeutic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Use Investing Themes to Complement your Cara Therapeutic position
In addition to having Cara Therapeutic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Air Thematic Idea Now
Air
Companies specializing in air services and air delivery. The Air theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Air Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
To fully project Cara Therapeutic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cara Therapeutic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cara Therapeutic's income statement, its balance sheet, and the statement of cash flows.